Results 91 to 100 of about 6,626 (113)

Adult Congenital Heart Disease. Follow-Up Pattern of Care. [PDF]

Arq Bras Cardiol
Amaral F, Figueiredo GL, Pavão RB, Manso PH, Gali LG, Wada DT, Schmidt A.   +6 more
europepmc   +1 more source

Characterization of the effect of naltrexone/bupropion on body composition. [PDF]

Diabetes Obes Metab
Tardio V, Yin P, Camacho F, Barakat M, Tsoukas MA.   +4 more
europepmc   +1 more source

Exploring the Correlations between Initial Clinical and Radiological Manifestations in Takayasu's Arteritis. [PDF]

Arq Bras Cardiol
Santana AUL, Shinjo SK.
europepmc   +1 more source

Golden Hour perception in a public maternity hospital: challenges and potentialities under a multi-professional team's vision. [PDF]

Rev Paul Pediatr
Dias JR, Valete COS.
europepmc   +1 more source

A cost-effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada. [PDF]

Diabetes Obes Metab
Gupta N, Babyak A, Chorbajian A, Tardio V, Ballreich J, Dasgupta K.   +5 more
europepmc   +1 more source

Fabry Disease and Its Different Phenotypes. [PDF]

Arq Bras Cardiol
Antunes MO, Nastari RR, Arteaga-Fernandez E, Lizandro MGH, El-Feghaly WB, Ferreira GJDS, Martins AS, Leguizamon JAGO, Correia VM, Madrini Junior V, Fernandes F.   +10 more
europepmc   +1 more source

Reversal of Left Bundle Branch Block Following Treatment in Alcoholic Cardiomyopathy. [PDF]

Arq Bras Cardiol
Barroso MCRD, Madogolele HDCN, Belfort DSP, Biselli B, Ayub-Ferreira SM, Bocchi EA.   +5 more
europepmc   +1 more source

Danon Disease: Understanding the Role of LAMP2 Variants in Cardiomyopathy and Multisystemic Involvement. [PDF]

Arq Bras Cardiol
Ribeiro GNP, Lipari LFVP, Senra PM, Pires LVL, Mizuta MH, Olivetti NQS, Aiello VD, Krieger JE.   +7 more
europepmc   +1 more source

Cardiogenic Shock Due to Inverted-Pattern Takotsubo Syndrome Caused by Pheochromocytoma: Case Report and Literature Review. [PDF]

Arq Bras Cardiol
Moraes PIM, Haddad MFA, Valle DBB, Oliveira Filho LO, Custódio MDS, Almeida DR.   +5 more
europepmc   +1 more source

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes. [PDF]

Diabetes Care
Graham TE, Raghinaru D, Afreen S, Ahmann A, Haidar A, Raskin P, Tsoukas MA, Lum JW, Sasson-Katchalski R, Pinsker JE, Beck RW, 2IQP Study Group* .   +11 more
europepmc   +1 more source